ClinicalTrials.Veeva

Menu

The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder

S

Shanghai Mental Health Center

Status

Not yet enrolling

Conditions

Obsessive-Compulsive Disorder
Virtual Reality

Treatments

Behavioral: Traditional ERP
Combination Product: The combination of exposure and response prevention (ERP) and VR

Study type

Interventional

Funder types

Other

Identifiers

NCT04534907
SMHC-OCD-009

Details and patient eligibility

About

This study will evaluate the clinical effectiveness ofthe Immersive Virtual Reality alongside exprosure and response Prevention (ERP) Treatment in cognitive-Behavioral Therapy for Obsessive-compulsive Disorder, and the underlying neural mechanism by electroencephalography (EEG) and eye-tracking methodology .

Full description

The current study aims to the clinical effectiveness of the Immersive Virtual Reality alongside exprosure and response Prevention (ERP) Treatment in cognitive-Behavioral Therapy for Obsessive-compulsive Disorder. 30 OCD patients whose symptom were mainly associated with "contamination/clean" , "Symmetry/precision", "Examination" and "Sex" will be randomized into two groups (i.e. VR ERP or ERP). The treatment will be performed twice a week for the first two weeks. And for the next 4 week, the treatment for OCD patients will be undertook once a week. There will be 8 times in total. The investigators will assess thhe OCD patients'symptom severity in the baseline, 2 weeks, 4weeks and after 8 weeks of the whole combined treatment. Through the study, Yale-Brown Obsessive Compulsive Scale(Y-BOCS), the Obsessive Compulsive Inventory-Revised (OCI-R), the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI), Perceived Stress Scale (PSS), Pittsburgh sleep quality index (PSQI) and side-effect questionnaire will be obtained by a trained investigator. The patients will also get individual's data of EEG and eye-movement.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age: 18-50 years old;
  • Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for OCD;
  • Y-BOCS total score > or = 16, discontinued medication for at least 8 weeks before
  • the enrollment or the paitients' clinical medication is stable for at least a month (the dose and the types of drugs) .>or=9 years education

Exclusion criteria

  • Any axis I psychiatric disorder comorbidity
  • Participants who have received any forms of psychological therapy in the past.
  • Patients cannot tolerate or adapt to the somatic discomfort caused by VR .
  • Prior history of neurological disease (e.g., epilepsy) or brain surgery for traumatic brain injury
  • Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
  • Any current significant medical condition.
  • serious suicide risk

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

VR(ERP)
Active Comparator group
Description:
The combination of exposure and response prevention (ERP) and VR will be applied twice a week for the fist two weeks. For the next four weeks, this treatment will be applied once a week. 8 times in total
Treatment:
Combination Product: The combination of exposure and response prevention (ERP) and VR
traditional ERP
Active Comparator group
Description:
The traditional ERP will be applied twice a week for the fist two weeks. For the next four weeks, this treatment will be applied once a week. 8 times in total
Treatment:
Behavioral: Traditional ERP

Trial contacts and locations

1

Loading...

Central trial contact

Zhen Wang, PhD,MD; Zhen Wang, PhD,MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems